Serina Therapeutics (SER) Current Deferred Revenue (2017 - 2020)
Serina Therapeutics (SER) posted Current Deferred Revenue of $275000.0 for Q4 2020, up 7.84% sequentially from $255000.0 in Q3 2020, and down 2.83% YoY from $283000.0 in Q1 2020.
Serina Therapeutics (SER) Current Deferred Revenue (2017 - 2020) Analysis & Trends
Serina Therapeutics has reported Current Deferred Revenue for 4 years, with the latest figure at $275000.0 in Q4 2020.
- Quarterly Current Deferred Revenue fell 2.83% year-over-year to $275000.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $275000.0 (down 2.83% YoY) and the FY2020 annual result came in at $275000.0, down 2.83% from the prior year.
- Current Deferred Revenue grew to $275000.0 in Q4 2020 per SER's latest filing, from $255000.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $407000.0 in Q1 2020 and troughed at $180000.0 in Q4 2017.
- A 4-year average of $281111.1 and a median of $275000.0 in 2020 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2018 and 2019: Current Deferred Revenue soared 76.11% in 2018, then fell 10.73% in 2019.
- Over 4 years, Current Deferred Revenue stood at $180000.0 in 2017, then jumped by 76.11% to $317000.0 in 2018, then dropped by 10.73% to $283000.0 in 2019, then dropped by 2.83% to $275000.0 in 2020.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $275000.0, $255000.0, and $328000.0 for Q4 2020, Q3 2020, and Q2 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Serina Therapeutics | 46.70 Mn | 23.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 275,000.00 |
| Sep 30, 2020 | 255,000.00 |
| Jun 30, 2020 | 328,000.00 |
| Mar 31, 2020 | 407,000.00 |
| Dec 31, 2019 | 283,000.00 |
| Sep 30, 2019 | 219,000.00 |
| Jun 30, 2019 | 266,000.00 |
| Dec 31, 2018 | 317,000.00 |
| Dec 31, 2017 | 180,000.00 |